Q3 FY2026 EarningsQ3 FY26 results presented a mixed performance: revenue of $1.066B missed the $1.098B consensus by 2.9%, while non-GAAP EPS of $1.15 beat the $1.12 estimate. GAAP EPS significantly outperformed due to a one-time $307.2M tax benefit. While CooperSurgical grew 3% organically, CooperVision revenue was flat YoY due to a proactive reduction in U.S. channel inventory, which management expects to persist into Q4. FY26 revenue guidance was slightly adjusted downwards compared to initial market expectations, though cash flow generation remains exceptionally strong.
Financial report interval: 2026.05.01 - 2026.07.31
Overview: Cooper Cos(COO) the Revenue is 1.066 B (+0.56%), Miss estimate;the EBIT is 280.7 M (+1.56%), Beat estimate;the EPS is 2.24 (+357.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
1.07B0.56%
1.10B3.58%
-0.03B3.02%
EBITExceed expectations
0.28B1.56%
0.28B0.18%
+0.00B1.38%
EPSExceed expectations
2.24357.14%
0.884380.47%
+1.3557276.67%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf